We recently demonstrated that three months of high-dose (4 g/daily) ω-3PUFA (fish oil, FO) supplementation improved insulin sensitivity, and decreased systemic and AT inflammation in individuals with obesity (BMI  ≥  30 kg/m<sup>2</sup>). The gene discussed is INS; the disease is obesity disorder.